SIRT1 is a signaling regulator and protein deubiquitination target that appears to sit at the intersection of autophagy, aging, and disease-associated signaling. It is implicated in autophagy and human longevity, and the literature here highlights modulation by bioactive natural compounds as well as direct post-translational regulation by l3emp. In one study, SIRT1 was described as…
The fda is the U.S. Food and Drug Administration, a regulatory body that shapes drug development and safety assessment, especially by promoting human-relevant New Approach Methodologies (NAMs) and model-informed drug development (MIDD). Its role is central in modernizing preclinical testing with organoid-based and other human-relevant systems, while also overseeing clinical translation in areas such as…
Tumor-infiltrating lymphocyte therapy, or tumor infiltrating lymphocyte therapy/TIL therapy, is a cell-based immunotherapy that uses autologous tumor-reactive lymphocytes to augment endogenous anti-tumor responses. It is typically a multistep regimen that includes non myeloablative lymphodepletion before infusion and high dose interleukin 2 afterward, with the therapeutic effect coming from the transferred TIL product rather than direct…
Hydrogen peroxide is a reactive oxygen species and oxidative DNA damage inducer that functions as a redox-active stress agent in experimental systems. It is used in a UV/H2O2 plasmid assay to assess DNA protection, and it can also act as a tumor microenvironment oxidant that is elevated in bladder cancer. In one cancer nanotherapy design,…
Regulatory T cells are an immunosuppressive T-cell population that helps maintain immune tolerance but can also promote tumor immune evasion, and in this context they are linked to lncrna-driven recruitment and polarization in gastric cancer. They are also a key target of ipilimumab, which in the described combination strategy depleted this population and reduced intratumoral…
